Concepedia

Samuel Haessig

SH

Statistics

Publications

3

Citations

54

H-Index

3

Active since

2008

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Samuel Haessig is an author at Novartis (Switzerland) specializing in medicinal chemistry, pharmacology, and drug design.

Publications per year

2008–2016

3

Publications

3

Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

Henri Mattes, Kumlesh K. Dev, Rochdi Bouhelal et al. · ChemMedChem · 2010 · 30 citations · Full text

, , +15

Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist

David Orain, Engin Tasdelen, Samuel Haessig et al. · ChemMedChem · 2016 · 12 citations

, , +13

A Novel Intramolecular Palladium-MediatedCyclization for the Synthesis of Substituted 2-(Aryl- or Benzylamino)-4<i>H</i>-1,3-Benzothiazines

David Orain, A.-C. Blumstein, Engin Tasdelen et al. · Synlett · 2008 · 12 citations

, , +7

1–3 of 3